Listed in the December 27, 2023 extract; not in the current extract (September 22, 2026): Ceftriaxone Sodium for Injection, BP (02250276), Ceftriaxone for Injection USP (02292866), Ceftriaxone Sodium for Injection, BP (02250292), Ceftriaxone for Injection USP (02292882), Ceftriaxone for Injection USP (02292904). Source: odb-formulary-ed43-extract-2023-12-27.xml; compared with odb-formulary-ed43-extract-2026-09-22.xml.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ceftriaxone disodium
10 general benefit · 6 not a benefit
Ceftriaxone Sodium For Injection BP · DIN 02325594 · 0.25 g/Vial · powder for injection, vial
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone Sodium For Injection BP · DIN 02325594
Manufacturer: Sterimax Inc.; listing date 2016-03-30
Health Canada: Marketed since 2011-04-23 · brand CEFTRIAXONE SODIUM FOR INJECTION BP · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intramuscular, Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 250 MG/VIAL · company Sterimax inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone Sodium For Injection BP: Formulary list price $5.64 per unit (the source does not state the unit; exact figure $5.6430). What the ministry pays, not the patient.
Ministry pays: $5.6430 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02325594)
Source record
DIN 02325594: Ceftriaxone Sodium For Injection BP
Raw flags: sec3=Y
Item: 081228043; group id 41; item number 0087; lccId None; manufacturer id STE
Source form: Inj Pd-Vial Pk; strength: 0.25g/Vial
Recorded listing: General benefit
Source prices (unrounded): $5.6430; ministry $5.6430
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02325594
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81096
Interchangeable products
Ceftriaxone Sodium for Injection BP · DIN 02292262 · $5.6430
Rocephin · DIN 00657387 · not recorded
Shortage status: To be discontinued; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02325594
Shortage record checked October 6, 2026
Ceftriaxone Sodium for Injection BP · DIN 02292262 · 0.25 g/Vial · powder for injection, vial
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone Sodium for Injection BP · DIN 02292262
Manufacturer: Sandoz Canada Inc.; listing date 2026-08-31
Health Canada: Marketed since 2018-03-15 · brand CEFTRIAXONE SODIUM FOR INJECTION BP · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intravenous, Intramuscular · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 250 MG/VIAL · company Sandoz canada incorporated · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone Sodium for Injection BP: Formulary list price $5.64 per unit (the source does not state the unit; exact figure $5.6430). What the ministry pays, not the patient.
Ministry pays: $5.6430 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02292262)
Source record
DIN 02292262: Ceftriaxone Sodium for Injection BP
Raw flags: sec3=Y
Item: 081228043; group id 41; item number 0087; lccId None; manufacturer id SDZ
Source form: Inj Pd-Vial Pk; strength: 0.25g/Vial
Recorded listing: General benefit
Source prices (unrounded): $5.6430; ministry $5.6430
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02292262
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77762
Interchangeable products
Ceftriaxone Sodium For Injection BP · DIN 02325594 · $5.6430
Rocephin · DIN 00657387 · not recorded
Shortage status: resolved shortage (ended January 8, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02292262
Shortage record checked October 6, 2026
Ceftriaxone · DIN 02292270 · 1 g/Vial · powder for injection, vial
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone · DIN 02292270
Manufacturer: Sandoz Canada Inc.; listing date 2007-05-04
Health Canada: Marketed since 2018-03-15 · brand CEFTRIAXONE SODIUM FOR INJECTION BP · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intramuscular, Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 1 G/VIAL · company Sandoz canada incorporated · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone: Formulary list price $12.50 per unit (the source does not state the unit; exact figure $12.4950). What the ministry pays, not the patient.
Ministry pays: $12.4950 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02292270)
Source record
DIN 02292270: Ceftriaxone
Raw flags: sec3=Y
Item: 081228045; group id 41; item number 0088; lccId None; manufacturer id SDZ
Source form: Inj Pd-Vial Pk; strength: 1g/Vial
Recorded listing: General benefit
Source prices (unrounded): $12.4950; ministry $12.4950
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02292270
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77763
Interchangeable products
Ceftriaxone Sodium For Injection BP · DIN 02325616 · $12.4950
Ceftriaxone Sodium for Injection · DIN 02287633 · $12.4950
Ceftriaxone for Injection · DIN 02289695 · $12.4950
Ceftriaxone for Injection USP · DIN 02292874 · $12.4950
Rocephin · DIN 00657417 · not recorded
Shortage status: resolved shortage (ended November 1, 2019); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02292270
Shortage record checked October 6, 2026
Ceftriaxone Sodium For Injection BP · DIN 02325616 · 1 g/Vial · powder for injection, vial
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone Sodium For Injection BP · DIN 02325616
Manufacturer: Sterimax Inc.; listing date 2016-03-30
Health Canada: Marketed since 2011-03-21 · brand CEFTRIAXONE SODIUM FOR INJECTION BP · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intramuscular, Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 1 G/VIAL · company Sterimax inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone Sodium For Injection BP: Formulary list price $12.50 per unit (the source does not state the unit; exact figure $12.4950). What the ministry pays, not the patient.
Ministry pays: $12.4950 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02325616)
Source record
DIN 02325616: Ceftriaxone Sodium For Injection BP
Raw flags: sec3=Y
Item: 081228045; group id 41; item number 0088; lccId None; manufacturer id STE
Source form: Inj Pd-Vial Pk; strength: 1g/Vial
Recorded listing: General benefit
Source prices (unrounded): $12.4950; ministry $12.4950
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02325616
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81098
Interchangeable products
Ceftriaxone · DIN 02292270 · $12.4950
Ceftriaxone Sodium for Injection · DIN 02287633 · $12.4950
Ceftriaxone for Injection · DIN 02289695 · $12.4950
Ceftriaxone for Injection USP · DIN 02292874 · $12.4950
Rocephin · DIN 00657417 · not recorded
Shortage status: resolved shortage (ended December 19, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02325616
Shortage record checked October 6, 2026
Ceftriaxone for Injection · DIN 02289695 · 1 g/Vial · powder for injection, vial
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone for Injection · DIN 02289695
Manufacturer: Fresenius Kabi Canada Ltd.; listing date 2025-03-31
Health Canada: Marketed since 2024-08-15 · brand CEFTRIAXONE FOR INJECTION · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intravenous, Intramuscular · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 1 G/VIAL · company Fresenius kabi canada ltd · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone for Injection: Formulary list price $12.50 per unit (the source does not state the unit; exact figure $12.4950). What the ministry pays, not the patient.
Ministry pays: $12.4950 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02289695)
Source record
DIN 02289695: Ceftriaxone for Injection
Raw flags: sec3=Y
Item: 081228045; group id 41; item number 0088; lccId None; manufacturer id FKC
Source form: Inj Pd-Vial Pk; strength: 1g/Vial
Recorded listing: General benefit
Source prices (unrounded): $12.4950; ministry $12.4950
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02289695
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77503
Interchangeable products
Ceftriaxone · DIN 02292270 · $12.4950
Ceftriaxone Sodium For Injection BP · DIN 02325616 · $12.4950
Ceftriaxone Sodium for Injection · DIN 02287633 · $12.4950
Ceftriaxone for Injection USP · DIN 02292874 · $12.4950
Rocephin · DIN 00657417 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02289695
Shortage record checked October 6, 2026
Ceftriaxone · DIN 02292289 · 2 g/Vial · powder for injection, vial
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone · DIN 02292289
Manufacturer: Sandoz Canada Inc.; listing date 2007-05-04
Health Canada: Marketed since 2018-03-15 · brand CEFTRIAXONE SODIUM FOR INJECTION BP · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intramuscular, Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 2 G/VIAL · company Sandoz canada incorporated · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone: Formulary list price $24.14 per unit (the source does not state the unit; exact figure $24.1395). What the ministry pays, not the patient.
Ministry pays: $24.1395 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02292289)
Source record
DIN 02292289: Ceftriaxone
Raw flags: sec3=Y
Item: 081228046; group id 41; item number 0089; lccId None; manufacturer id SDZ
Source form: Inj Pd-Vial Pk; strength: 2g/Vial
Recorded listing: General benefit
Source prices (unrounded): $24.1395; ministry $24.1395
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02292289
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77764
Interchangeable products
Ceftriaxone Sodium For Injection BP · DIN 02325624 · $24.1395
Ceftriaxone for Injection · DIN 02289709 · $24.1395
Rocephin · DIN 00657409 · not recorded
Shortage status: shortage reported ended September 8, 2026 (report last updated September 8, 2026); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02292289
Shortage record checked October 6, 2026
Ceftriaxone Sodium For Injection BP · DIN 02325624 · 2 g/Vial · powder for injection, vial
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone Sodium For Injection BP · DIN 02325624
Manufacturer: Sterimax Inc.; listing date 2016-03-30
Health Canada: Marketed since 2011-01-31 · brand CEFTRIAXONE SODIUM FOR INJECTION BP · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intramuscular, Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 2 G/VIAL · company Sterimax inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone Sodium For Injection BP: Formulary list price $24.14 per unit (the source does not state the unit; exact figure $24.1395). What the ministry pays, not the patient.
Ministry pays: $24.1395 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02325624)
Source record
DIN 02325624: Ceftriaxone Sodium For Injection BP
Raw flags: sec3=Y
Item: 081228046; group id 41; item number 0089; lccId None; manufacturer id STE
Source form: Inj Pd-Vial Pk; strength: 2g/Vial
Recorded listing: General benefit
Source prices (unrounded): $24.1395; ministry $24.1395
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02325624
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81099
Interchangeable products
Ceftriaxone · DIN 02292289 · $24.1395
Ceftriaxone for Injection · DIN 02289709 · $24.1395
Rocephin · DIN 00657409 · not recorded
Shortage status: resolved shortage (ended December 19, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02325624
Shortage record checked October 6, 2026
Ceftriaxone for Injection · DIN 02289709 · 2 g/Vial · powder for injection, vial
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone for Injection · DIN 02289709
Manufacturer: Fresenius Kabi Canada Ltd.; listing date 2025-03-31
Health Canada: Marketed since 2024-08-15 · brand CEFTRIAXONE FOR INJECTION · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intramuscular, Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 2 G/VIAL · company Fresenius kabi canada ltd · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone for Injection: Formulary list price $24.14 per unit (the source does not state the unit; exact figure $24.1395). What the ministry pays, not the patient.
Ministry pays: $24.1395 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02289709)
Source record
DIN 02289709: Ceftriaxone for Injection
Raw flags: sec3=Y
Item: 081228046; group id 41; item number 0089; lccId None; manufacturer id FKC
Source form: Inj Pd-Vial Pk; strength: 2g/Vial
Recorded listing: General benefit
Source prices (unrounded): $24.1395; ministry $24.1395
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02289709
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77504
Interchangeable products
Ceftriaxone · DIN 02292289 · $24.1395
Ceftriaxone Sodium For Injection BP · DIN 02325624 · $24.1395
Rocephin · DIN 00657409 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02289709
Shortage record checked October 6, 2026
Ceftriaxone Sodium For Injection BP · DIN 02292297 · 10 g/Vial · powder for injection, vial
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked November 17, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone Sodium For Injection BP · DIN 02292297
Manufacturer: Sandoz Canada Inc.; listing date 2022-04-29
Health Canada: Marketed since 2018-03-15 · brand CEFTRIAXONE SODIUM FOR INJECTION BP · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 10 G/VIAL · company Sandoz canada incorporated · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone Sodium For Injection BP: Formulary list price $214.20 per unit (the source does not state the unit; exact figure $214.2000). What the ministry pays, not the patient.
Ministry pays: $214.2000 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02292297)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02292297).
DIN 02292297: Ceftriaxone Sodium For Injection BP
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081228121; group id 41; item number 0090; lccId None; manufacturer id SDZ
Source form: Inj Pd-Vial Pk; strength: 10g/Vial
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $214.2000; ministry $214.2000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02292297
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77765
Interchangeable products
Ceftriaxone Sodium For Injection BP · DIN 02325632 · $214.2000
Rocephin · DIN 00851957 · not recorded
Shortage status: resolved shortage (ended April 20, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02292297
Shortage record checked October 6, 2026
Ceftriaxone Sodium For Injection BP · DIN 02325632 · 10 g/Vial · powder for injection, vial
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone Sodium For Injection BP · DIN 02325632
Manufacturer: Sterimax Inc.; listing date 2016-03-30
Health Canada: Marketed since 2011-03-21 · brand CEFTRIAXONE SODIUM FOR INJECTION BP · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 10 G/VIAL · company Sterimax inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone Sodium For Injection BP: Formulary list price $214.20 per unit (the source does not state the unit; exact figure $214.2000). What the ministry pays, not the patient.
Ministry pays: $214.2000 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02325632)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02325632).
DIN 02325632: Ceftriaxone Sodium For Injection BP
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081228121; group id 41; item number 0090; lccId None; manufacturer id STE
Source form: Inj Pd-Vial Pk; strength: 10g/Vial
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $214.2000; ministry $214.2000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02325632
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81100
Interchangeable products
Ceftriaxone Sodium For Injection BP · DIN 02292297 · $214.2000
Rocephin · DIN 00851957 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02325632
Shortage record checked October 6, 2026
Ceftriaxone Sodium for Injection · DIN 02287633 · 1 g/Vial · powder for injection, vial
General benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-30 — choose a marketed DIN from the same-category list.Discontinued July 30, 2025 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-30 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-07-30 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone Sodium for Injection · DIN 02287633
Manufacturer: Teva Canada Limited; listing date 2008-03-25
Health Canada: Cancelled post market since 2025-07-30 · brand CEFTRIAXONE SODIUM FOR INJECTION · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intravenous, Intramuscular · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 1 G/VIAL · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone Sodium for Injection: Formulary list price $12.50 per unit (the source does not state the unit; exact figure $12.4950). What the ministry pays, not the patient.
Ministry pays: $12.4950 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02287633)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02287633).
DIN 02287633: Ceftriaxone Sodium for Injection
Raw flags: dinStatus=E, sec3=Y
Item: 081228045; group id 41; item number 0088; lccId None; manufacturer id TEV
Source form: Inj Pd-Vial Pk; strength: 1g/Vial
Recorded listing: General benefit; DIN status E, meaning unconfirmed
Source prices (unrounded): $12.4950; ministry $12.4950
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02287633
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77304
Interchangeable products
Ceftriaxone · DIN 02292270 · $12.4950
Ceftriaxone Sodium For Injection BP · DIN 02325616 · $12.4950
Ceftriaxone for Injection · DIN 02289695 · $12.4950
Ceftriaxone for Injection USP · DIN 02292874 · $12.4950
Rocephin · DIN 00657417 · not recorded
Shortage status: discontinued (February 5, 2021, reported by TEVA CANADA LIMITED); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02287633
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 30, 2025 — choose a marketed DIN from the same-category list.
Ceftriaxone for Injection USP · DIN 02292874 · 1 g/Vial · powder for injection, vial
General benefit; Health Canada lists this DIN as Cancelled post market since 2019-06-28 — choose a marketed DIN from the same-category list.Discontinued June 28, 2019 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2019-06-28 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2019-06-28 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Ceftriaxone for Injection USP · DIN 02292874
Manufacturer: Orchid Healthcare; listing date 2008-01-15
Health Canada: Cancelled post market since 2019-06-28 · brand CEFTRIAXONE FOR INJECTION USP · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intramuscular, Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 1 G/VIAL · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCeftriaxone for Injection USP: Formulary list price $12.50 per unit (the source does not state the unit; exact figure $12.4950). What the ministry pays, not the patient.
Ministry pays: $12.4950 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02292874)
Source record
DIN 02292874: Ceftriaxone for Injection USP
Raw flags: sec3=Y
Item: 081228045; group id 41; item number 0088; lccId None; manufacturer id ORC
Source form: Inj Pd-Vial Pk; strength: 1g/Vial
Recorded listing: General benefit
Source prices (unrounded): $12.4950; ministry $12.4950
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02292874
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77822
Interchangeable products
Ceftriaxone · DIN 02292270 · $12.4950
Ceftriaxone Sodium For Injection BP · DIN 02325616 · $12.4950
Ceftriaxone Sodium for Injection · DIN 02287633 · $12.4950
Ceftriaxone for Injection · DIN 02289695 · $12.4950
Rocephin · DIN 00657417 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02292874
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 28, 2019 — choose a marketed DIN from the same-category list.
Rocephin · DIN 00657387 · 0.25 g/Vial · powder for injection, vial
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2012-06-20 — choose a marketed DIN from the same-category list.Discontinued June 20, 2012 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2012-06-20 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2012-06-20 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Rocephin · DIN 00657387
Manufacturer: Hoffmann-La Roche Limited; listing date 1996-10-01
Health Canada: Cancelled post market since 2012-06-20 · brand ROCEPHIN PWS INJ 0.25GM/VIAL · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intravenous, Intramuscular · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 250 MG/VIAL · company Hoffmann-la roche limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRocephin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00657387)
Source record
DIN 00657387: Rocephin
Raw flags: notABenefit=Y, sec3=Y
Item: 081228043; group id 41; item number 0087; lccId None; manufacturer id HLR
Source form: Inj Pd-Vial Pk; strength: 0.25g/Vial
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00657387
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8037
Interchangeable products
Ceftriaxone Sodium For Injection BP · DIN 02325594 · $5.6430
Ceftriaxone Sodium for Injection BP · DIN 02292262 · $5.6430
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00657387
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 20, 2012 — choose a marketed DIN from the same-category list.
Rocephin · DIN 00657417 · 1 g/Vial · powder for injection, vial
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2011-10-17 — choose a marketed DIN from the same-category list.Discontinued October 17, 2011 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2011-10-17 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2011-10-17 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Rocephin · DIN 00657417
Manufacturer: Hoffmann-La Roche Limited; listing date 1996-10-01
Health Canada: Cancelled post market since 2011-10-17 · brand ROCEPHIN PWS 1GM/VIAL · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intravenous, Intramuscular · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 1 G/VIAL · company Hoffmann-la roche limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRocephin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00657417)
Source record
DIN 00657417: Rocephin
Raw flags: notABenefit=Y, sec3=Y
Item: 081228045; group id 41; item number 0088; lccId None; manufacturer id HLR
Source form: Inj Pd-Vial Pk; strength: 1g/Vial
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00657417
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8074
Interchangeable products
Ceftriaxone · DIN 02292270 · $12.4950
Ceftriaxone Sodium For Injection BP · DIN 02325616 · $12.4950
Ceftriaxone Sodium for Injection · DIN 02287633 · $12.4950
Ceftriaxone for Injection · DIN 02289695 · $12.4950
Ceftriaxone for Injection USP · DIN 02292874 · $12.4950
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00657417
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 17, 2011 — choose a marketed DIN from the same-category list.
Rocephin · DIN 00657409 · 2 g/Vial · powder for injection, vial
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-07-29 — choose a marketed DIN from the same-category list.Discontinued July 29, 2009 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-07-29 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2009-07-29 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Rocephin · DIN 00657409
Manufacturer: Hoffmann-La Roche Limited; listing date 1996-10-01
Health Canada: Cancelled post market since 2009-07-29 · brand ROCEPHIN PWS 2GM/VIAL · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intravenous, Intramuscular · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 2 G/VIAL · company Hoffmann-la roche limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRocephin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00657409)
Source record
DIN 00657409: Rocephin
Raw flags: notABenefit=Y, sec3=Y
Item: 081228046; group id 41; item number 0089; lccId None; manufacturer id HLR
Source form: Inj Pd-Vial Pk; strength: 2g/Vial
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00657409
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8038
Interchangeable products
Ceftriaxone · DIN 02292289 · $24.1395
Ceftriaxone Sodium For Injection BP · DIN 02325624 · $24.1395
Ceftriaxone for Injection · DIN 02289709 · $24.1395
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00657409
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 29, 2009 — choose a marketed DIN from the same-category list.
Rocephin · DIN 00851957 · 10 g/Vial · powder for injection, vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2009-07-29 — choose a marketed DIN from the same-category list.Discontinued July 29, 2009 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2009-07-29 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2009-07-29 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Rocephin · DIN 00851957
Manufacturer: Hoffmann-La Roche Limited; listing date 2008-08-28
Health Canada: Cancelled post market since 2009-07-29 · brand ROCEPHIN INJ 10GM/VIAL · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 10 G/VIAL · company Hoffmann-la roche limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRocephin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00851957)
Source record
DIN 00851957: Rocephin
Raw flags: sec3=Y, sec3b=Y
Item: 081228121; group id 41; item number 0090; lccId None; manufacturer id HLR
Source form: Inj Pd-Vial Pk; strength: 10g/Vial
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00851957
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10475
Interchangeable products
Ceftriaxone Sodium For Injection BP · DIN 02292297 · $214.2000
Ceftriaxone Sodium For Injection BP · DIN 02325632 · $214.2000
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00851957
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 29, 2009 — choose a marketed DIN from the same-category list.
Other products in the same Health Canada class (J01D, J01DD): coverage varies; not interchangeable
- Cefixime (Suprax): general benefit
- Cefadroxil (Duricef): general benefit, not a benefit
- Cefprozil (Ran-Cefprozil): general benefit, not a benefit
- Cefuroxime axetil (Ceftin): general benefit, not a benefit
- Cephalexin (Ceporex): general benefit, not a benefit
- Cefazolin (Cefazolin for Injection): not a benefit
1 more in the class list below
Other drugs in the same formulary class (08:12:28 Other Antibiotics) and how they are covered
Matched class: 08:12:28 Other Antibiotics
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Covered without a code on the Ontario formulary: CEFIXIME, CLINDAMYCIN PALMITATE
Some products covered without a code (check the product listing): CEFADROXIL, CEFPROZIL, CEFUROXIME AXETIL, CEPHALEXIN MONOHYDRATE, CLINDAMYCIN HCL, TOBRAMYCIN, TOBRAMYCIN SULFATE
08:12:28 Other Antibiotics
· 4 products · General benefit · strengths: 20mg/mL, 400mg · Oral Susp, Tab
· 4 products · Listed, not a benefit (1), General benefit (3) · strengths: 500mg · Cap
· 17 products · General benefit (11), Listed, not a benefit (6) · strengths: 125mg/5mL, 250mg/5mL, 250mg, 500mg · Oral Susp-100mL Pk, Oral Susp-75mL Pk, Tab
· 9 products · General benefit (7), Listed, not a benefit (2) · strengths: 125mg/5mL, 250mg, 500mg · Susp, Tab
· 29 products · Listed, not a benefit (6), General benefit (23) · strengths: 250mg, 500mg, 25mg/mL, 50mg/mL · Cap, Pd for Oral Susp, Tab
· 15 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg/Vial, 1g/Vial, 10g/Vial · Inj Pd-Vial Pk, Inj Pd-Vial Pk (Preservative-Free)
· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1g/Vial, 2g/Vial · Inj Pd-Vial Pk
· 22 products · Listed, not a benefit (2), General benefit (20) · strengths: 150mg, 300mg · Cap
· 1 products · General benefit · strengths: 15mg/mL · Pd for Oral Susp
· 3 products ·
Limited Use, codes 472 (1), General benefit (2) · strengths: 28mg, 300mg/5mL · Inh Pd-Cap, Inh Sol-5mL Pk
· 4 products · Listed, not a benefit (1), General benefit (3) · strengths: 80mg/2mL · Inj Sol-2mL Pk
· 1 products ·
Limited Use, codes 677 · strengths: 500mg/Vial · Pd for Sol (Preservative-Free)
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 08:12:28
and 4 more
Full class listing
Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:16 Penicillins, 08:12:24 Tetracyclines, 08:14:08 Azoles
Same formulary class, not same indication: class membership alone does not establish equivalent uses.
Other drugs whose Health Canada label lists a similar indication: bone and joint infections, intra-abdominal infections, lower respiratory tract infections, skin and skin structure infections, urinary tract infections
From Health Canada product monographs; label wording only, not a treatment recommendation.
Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ.
No displayed matched alternative is a general benefit.
CEFOXITIN SODIUM · Off-Formulary Interchangeable, not an ODB benefit
1 - Intra-abdominal infections such as peritonitis and intra-abdominal abscess
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
4 - Urinary tract infections (including those caused by Serratia marcescens and Serratia spp.)
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
5 - Lower respiratory tract infections
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
6 - Bone and joint infections caused by Staphylococcus aureus
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
CLINDAMYCIN PHOSPHATE · General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1), Listed, not a benefit (1)
• Skin and skin structure infections including cellulitis, abscesses, and wound infections
when caused by Streptococcus pyogenes, Staphylococcus aureus and anaerobes.
PM: https://pdf.hres.ca/dpd_pm/00085906.PDF; date AUG 27, 2026; DIN 02230540; fetched 2026-09-10
Product monograph
• Intra-abdominal infections including peritonitis and abdominal abscess when caused by
susceptible anaerobes. Clindamycin should be given in conjunction with an antibiotic of
appropriate gram negative aerobic spectrum.
PM: https://pdf.hres.ca/dpd_pm/00085906.PDF; date AUG 27, 2026; DIN 02230540; fetched 2026-09-10
Product monograph
• Bone and joint infections including osteomyelitis and septic arthritis when caused by
sensitive strains of Staphylococcus aureus and anaerobes.
PM: https://pdf.hres.ca/dpd_pm/00085906.PDF; date AUG 27, 2026; DIN 02230540; fetched 2026-09-10
Product monograph
AMOXICILLIN & CLAVULANIC ACID · General benefit (22), Listed, not a benefit (3)
• Lower Respiratory Tract Infections when caused by β-lactamase producing strains of H. influenzae,
K. pneumoniae, S. aureus or Moraxella (Branhamella) catarrhalis.
PM: https://pdf.hres.ca/dpd_pm/00084428.PDF; date 2026-04-24; DIN 01916874; fetched 2026-09-10
Product monograph
CEFADROXIL · Listed, not a benefit (1), General benefit (3)
• Skin and skin structure infections caused by Staphylococcus aureus and/or Group A ß–
hemolytic streptococci.
PM: https://pdf.hres.ca/dpd_pm/00056563.PDF; date May 20, 2020; DIN 02235134; fetched 2026-09-10
Product monograph
Coverage source: ON formulary extract 2026-09-22